Home | PHARMAC
Home | PHARMAC
  • Website
  • Application Tracker
  • Schedule
  • About PHARMAC
    • About PHARMAC
    • Your guide to PHARMAC
    • Our people
    • Careers at PHARMAC
    • Expert advice
    • PHARMAC's performance
    • Operating policies and procedures
    • Year in review 2018
    • Strategies
  • Medicines
    • Medicines
    • How medicines are funded
    • Medicines information
    • My medicine or medical device has changed
    • Your health
    • Hospital pharmaceuticals
    • New medicines – from development to funding
    • Equity
  • Hospital devices
    • Hospital devices
    • Feedback on managing fairer access to hospital medical devices
    • What's happening in each category?
    • About our role in device management
    • Device Advice
  • News
  • Te Whaioranga
    • Te Whaioranga
    • Te Whaioranga 2013 - 2023: Māori Responsiveness Strategy
    • Whānau Ora
    • He Rongoā Pai, He Oranga Whānau
    • Scholarships
    • Hauora Arotahi - Māori health areas of focus
    • Māori Responsiveness Team
    • One Heart Many Lives
  • Pacific
    • Pacific
    • Pacific responsiveness strategy 2017-2026
    • Stage one: Pacific Responsiveness Strategy
  • Tools & resources
    • Tools & resources
    • Pharmaceutical Schedule
    • Annual Procurement Plan
    • Forms
    • Research
    • Print and PDF resources
    • Glossary
    • PHARMAC labelling preferences for prescription pharmaceuticals
  • Information for…
  1. News /
  2. RFP - supply of rituximab

See more about this section

News

  • Media releases
  • Notifications
  • Consultations
  • Tenders
  • RFPs
  • OIA responses

News

  • Media releases
  • Notifications
  • Consultations
  • Tenders
  • RFPs
  • OIA responses

RFP - supply of rituximab

16 July 2019

PHARMAC invites proposals for the supply of rituximab in New Zealand.

This request for proposals (RFP) document incorporates the following schedules:

  • Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
  • Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
  • Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
  • Schedule 4 contains the RFP form in which you are to provide details of your proposal [DOCX, 23 KB].

Full text of RFP - supply of rituximab [PDF, 124 KB]

PHARMAC's standard terms and conditions [PDF, 79 KB]

If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no later than 5pm NZT Monday 12 August 2019 - RFx ID 21271575.

We encourage suppliers to register with GETS and subscribe to this RFP. If you have any questions about this RFP, please post these on GETS (www.gets.govt.nz(external link)). 

We look forward to receiving your proposal.

 

Last updated: 16 July 2019

About this site

  • Sitemap
  • Copyright
  • Disclaimer
  • Privacy statement
  • Website changes
  • About this site

Contact

  • Contact us
  • Twitter - PHARMACnz
  • Facebook - PHARMACnz
  • YouTube - PHARMACgovtnz
  • LinkedIn - Pharmaceutical Management Agency (PHARMAC)
  • Careers
  • Newsfeed
  • Subscribe

Back to top

New Zealand Government